A Cell Host Microbe paper argues bacterial antiphage defenses have counterparts in human immune genes.
Vincent says nothing was promised; it was only a theory. Older people being infected now never met SARS-CoV-2 young, and because they immunosenesce they make poor T-cell immunity, so reinfection still brings severe disease. Until everyone is first infected at a young age, which may take a couple of generations, severe disease continues.
Answered around 6:39The paper is conservation of antiviral systems across domains of life reveals immune genes in humans. It runs the usual logic backwards: instead of hunting eukaryotic defences inside bacteria, it sifts bacterial antiphage systems for similar immune functions encoded in eukaryotic genomes, all the way out to humans.
Answered around 11:38The authors work from 132 antiphage systems encoded by bacteria, a lot of them discovered only in the last few years. In most cases the mechanism is unknown; all that is known is that they reduce the ability of phages to propagate or replicate.
Answered around 27:18Mokosh, named after the goddess protector of women's destiny in Slavic mythology; Elios, the Greek goddess of mercy; and Lamassu, a Mesopotamian celestial being with a human head for intelligence, a bull's body for strength and eagle's wings for freedom. Each is several bacterial genes executing an immune response.
Answered around 30:31PLD6, a phospholipase D family member involved in mitochondrial biology and proposed to add specificity to the piRNA pathway, plus the RNA helicase MOV10L1 in that same pathway. Nels calls the evidence consistent but circumstantial, noting the human structure predictions include low-confidence spaghetti-like regions.
Answered around 42:13Humans encode about eight GIMAPs, bats perhaps ten, and fish can have as many as 150. Nels compares these immune gene families to an accordion breathing across lineages. His own lab saw zebrafish GIMAPs turned up in fish infected with a natural zebrafish picornavirus.
Answered around 49:19They disrupted GMAP5 and 6 in human cells using silencing rather than CRISPR, then tested herpes simplex virus 1. Fewer cells got infected, and in those that did, fewer viruses were produced. Nels calls the effect pretty subtle and the virology a little tacked on.
Answered around 50:59Nels says no: thwart means block, and they only reduced infection rather than blocking it. Biological relevance isn't clear and it needs more work. Choosing herpes wasn't motivated in the manuscript; ideally a panel of viruses would be used. Vincent notes VSV was unaffected by the GMAP5 and 6 changes.
Answered around 53:50Three genes sitting next to each other in our genomes: FHAD1, forkhead-associated phospholipoprotein binding domain 1; CTRC, chymotrypsin, a protease; and EFHD2, EF-hand domain-containing protein D2. EFHD2 has published evidence of binding HSV1 capsids, supplying the sensing, with the protease as the effector.
Answered around 59:53Nels sees no risk. The closest thing is the chimeric protein splicing an Elios GTPase domain onto the rest of GMAP6, done only in cells, not in humans, germlines or animals, and aimed at a better immune gene. Vincent adds that most gain-of-function research is absolutely fine.
Answered around 1:23:09“There are no promises in science.”
“And by giant viruses, we're not bluffing here.”
“They said it's cheaper to buy plastic and throw it away.”
“Most of science isn't that.”
“Conservation of Antiviral Systems.” https://traffic.libsyn.com/secure/twievo/TWiEVO106.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/conservation-of-antiviral-systems.html.